These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 29736435)

  • 21. Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention.
    Dawei W; Shuangman M; Huiyao H; Dandan C; Yu T; Ning L
    Front Med (Lausanne); 2022; 9():1082445. PubMed ID: 36582284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug interventions for the treatment of obesity in children and adolescents.
    Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unblinding of trial participants to their treatment allocation: lessons from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER).
    Dinnett EM; Mungall MM; Kent JA; Ronald ES; McIntyre KE; Anderson E; Gaw A;
    Clin Trials; 2005; 2(3):254-9. PubMed ID: 16279148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re-evaluating design specifications of longitudinal clinical trials without unblinding when the key response is rate of change.
    Shih WJ; Gould AL
    Stat Med; 1995 Oct; 14(20):2239-48. PubMed ID: 8552900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rater bias in a blinded randomized placebo-controlled psychiatry trial.
    Marcus SM; Gorman JM; Tu X; Gibbons RD; Barlow DH; Woods SW; Katharine Shear M
    Stat Med; 2006 Aug; 25(16):2762-70. PubMed ID: 16345016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simulating therapeutic drug monitoring results for dose individualisation to maintain investigator blinding in a randomised controlled trial.
    Lesosky M; Joska J; Decloedt E
    Trials; 2017 Jun; 18(1):261. PubMed ID: 28592271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparability of blinded remote and site-based assessments of response to adjunctive esketamine or placebo nasal spray in patients with treatment resistant depression.
    Targum SD; Daly E; Fedgchin M; Cooper K; Singh JB
    J Psychiatr Res; 2019 Apr; 111():68-73. PubMed ID: 30685564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blinding, unblinding, and the placebo effect: an analysis of patients' guesses of treatment assignment in a double-blind clinical trial.
    Moscucci M; Byrne L; Weintraub M; Cox C
    Clin Pharmacol Ther; 1987 Mar; 41(3):259-65. PubMed ID: 3816016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials.
    Boutron I; Tubach F; Giraudeau B; Ravaud P
    J Clin Epidemiol; 2004 Jun; 57(6):543-50. PubMed ID: 15246122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The unblinding of statisticians in clinical trials: commentary on Iflaifel et al., Trials 2023.
    Parker RA
    Trials; 2023 Sep; 24(1):579. PubMed ID: 37691093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methods of blinding in reports of randomized controlled trials assessing pharmacologic treatments: a systematic review.
    Boutron I; Estellat C; Guittet L; Dechartres A; Sackett DL; Hróbjartsson A; Ravaud P
    PLoS Med; 2006 Oct; 3(10):e425. PubMed ID: 17076559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
    Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
    Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blinding in randomised trials: hiding who got what.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can trials of physical treatments be blinded? The example of transcutaneous electrical nerve stimulation for chronic pain.
    Deyo RA; Walsh NE; Schoenfeld LS; Ramamurthy S
    Am J Phys Med Rehabil; 1990 Feb; 69(1):6-10. PubMed ID: 2137345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating preference effects in partially unblinded, randomized clinical trials.
    Halpern SD
    J Clin Epidemiol; 2003 Feb; 56(2):109-15. PubMed ID: 12654404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digital blinding of radiographs to mask allocation in a randomized control trial.
    Slobogean GP; Soswa L; Rotunno G; O'Brien PJ; Lefaivre KA
    World J Orthop; 2017 Oct; 8(10):785-789. PubMed ID: 29094009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative management following closed reduction of traumatic anterior dislocation of the shoulder.
    Braun C; McRobert CJ
    Cochrane Database Syst Rev; 2019 May; 5(5):CD004962. PubMed ID: 31074847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decision on performing interim analysis for comparative clinical trials.
    Pak K; Jacobus S; Uno H
    Contemp Clin Trials Commun; 2017 Sep; 7():224-230. PubMed ID: 29696190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interventions for Old World cutaneous leishmaniasis.
    Heras-Mosteiro J; Monge-Maillo B; Pinart M; Lopez Pereira P; Reveiz L; Garcia-Carrasco E; Campuzano Cuadrado P; Royuela A; Mendez Roman I; López-Vélez R
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005067. PubMed ID: 29149474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.